Tristetraprolin Is a Prognostic Biomarker for Poor Outcomes among Patients with Low-Grade Prostate Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tristetraprolin Is a Prognostic Biomarker for Poor Outcomes among Patients with Low-Grade Prostate Cancer

Published:2018-08-14 Issue:11 Volume:27 Page:1376-1383
ISSN:1055-9965
Container-title:Cancer Epidemiology Biomarkers & Prevention
language:en
Short-container-title:Cancer Epidemiol Biomarkers Prev

Author:

Rounbehler Robert J.,Berglund Anders E.,Gerke Travis,Takhar Mandeep M.,Awasthi Shivanshu,Li Weimin,Davicioni Elai^ORCID,Erho Nicholas G.,Ross Ashley E.,Schaeffer Edward M.,Klein Eric A.,Karnes R. Jeffrey,Jenkins Robert B.,Cleveland John L.,Park Jong Y.,Yamoah Kosj^ORCID

Funder

HHS | NIH | National Cancer Institute (NCI)

Prostate Cancer Foundation (PCF)

American Cancer Society (ACS)

Cortner Couch Endowed Chair, College of Medicine at the University of South Florida

Moffitt Team Science

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology,Epidemiology

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances of nucleic acid-based cancer biomarkers and biosensors;Coordination Chemistry Reviews;2023-12

2. Tristetraprolin expression levels and methylation status in breast cancer;Gene Reports;2023-03

3. Loss of tristetraprolin activates NF-κB induced phenotypic plasticity and primes transition to lethal prostate cancer;2022-08-05

4. Integrated Analysis and Identification of Critical RNA-Binding Proteins in Bladder Cancer;Cancers;2022-07-31

5. Tristetraproline in breast cancer: treat or trick?;2022-05-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP